Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03411109 · ClinicalTrials.gov registry record

Outcomes of Intrathecal Analgesia in Colorectal Surgery

A clinical trial of Surgery, sponsored by Mayo Clinic.

Completed
Registry status
601
Enrollment target
2
Study locations

NCT03411109 is a study of Surgery that has completed, run by Mayo Clinic. The registered enrollment target is 601 participants, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03411109, a study of Surgery, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
601 participants
Enrollment target
2
Study locations

Study Summary

Multimodal analgesia, sometimes including intrathecal analgesia (IA), is essential in any enhanced recovery pathway (ERP). This study aimed to evaluate the safety, feasibility, and optimal IA regimen in colorectal surgical patients.

Conditions Studied

Surgery

Interventions

  • DRUG Hydromorphone Hydrochloride

Study Locations (2)

Florida

  • Mayo Clinic - Jacksonville

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 601 participants
Start Date 2012-10-01
Est. Completion 2013-12-31

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03411109

The ClinicalTrials.gov registry entry for NCT03411109 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 601 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Hydromorphone Hydrochloride is the first listed.

NCT03411109 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT03411109 about?

NCT03411109 is a clinical study titled "Outcomes of Intrathecal Analgesia in Colorectal Surgery". Multimodal analgesia, sometimes including intrathecal analgesia (IA), is essential in any enhanced recovery pathway (ERP). This study aimed to evaluate the safety, feasibility, and optimal IA regimen in colorectal surgical patients.

What is the current status of trial NCT03411109?

This trial is currently completed. The enrollment target is 601 participants. The study started on 2012-10-01. Estimated completion is 2013-12-31.

What conditions does trial NCT03411109 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT03411109?

The interventions under investigation include: Hydromorphone Hydrochloride (DRUG).

Who is sponsoring clinical trial NCT03411109?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03411109 being conducted?

This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Surgery

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.